Mesothelioma Asbestos Cancer Information

  Malignant peritoneal pleural mesothelioma asbestos cancer and treatment information 

>> What is Mesothelioma?

>> What is the Mesothelium?

>> Mesothelioma Symptoms

>> Mesothelioma Diagnosed

>> Mesothelioma Treatment

>> Mesothelioma Studies

>> Risk Factors

>> Who is at Increased Risk

>> What is Asbestos?

>> Metastatic Cancer Info

>> Mesothelioma Updates

>> Health Professionals

>> Mesothelioma advanced stages(II,III,IV)

>> Mesothelioma cellular classification

>> Mesothelioma general information

>> Mesothelioma Lawyer & Attorney Rights

>> Mesothelioma localized stage I

>> Recurrent mesothelioma

>> Different stages of mesothelioma

>> who requires examination

>> Frequently asked questions

>> Government and asbestos protection

>> hazards of asbestos

>> Environmental exposure

>> Asbestos information-sources

>> Asbestos workers protection

>> Extent of risk

>> Smoking causes higher risk

>> Usage of asbestos

>> First Aid - Emergency Instructions

>> Links

 

 

 

 

 

Mesothelioma Stage Information

Patients with stage I disease have a significantly better prognosis than those with more advanced stages. However, because of the relative rarity of this disease, exact survival information based upon stage is limited.[1] A proposed staging system based upon thoracic surgery principles and clinical data is shown below.[2] It is a modification of the older system proposed by Butchart et al.[3] Other staging systems that have been employed, including a proposed new international TNM staging system, are summarized by the International Mesothelioma Interest Group.[4]

  • Stage I: Disease confined within the capsule of the parietal pleura: ipsilateral pleura, lung, pericardium, and diaphragm.
  • Stage II: All of stage I with positive intrathoracic (N1 or N2) lymph nodes.
  • Stage III: Local extension of disease into the following: chest wall or mediastinum; heart or through the diaphragm, peritoneum; with or without extrathoracic or contralateral (N3) lymph node involvement.
  • Stage IV: Distant metastatic disease.

Localized malignant mesothelioma

See description of stage I above.

Advanced malignant mesothelioma

See descriptions of stages II, III, and IV above.

For the purposes of the discussion of treatment in this summary, the disease is categorized as either localized or advanced.

References

  1. Chahinian AP, Pass HI: Malignant mesothelioma. In: Holland JC, Frei E, eds.: Cancer Medicine e.5. 5th ed. Hamilton, Ontario: B.C. Decker Inc, 2000, pp 1293-1312. 

  2. Sugarbaker DJ, Strauss GM, Lynch TJ, et al.: Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol 11 (6): 1172-8, 1993.  [PUBMED Abstract]

  3. Butchart EG, Ashcroft T, Barnsley WC, et al.: Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 31 (1): 15-24, 1976.  [PUBMED Abstract]

  4. Rusch VW: A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 108 (4): 1122-8, 1995.  [PUBMED Abstract]
 

 

 

 

# # # 
Sources of National Cancer Institute Information

 

 

Mesothilioma, Mesotheliema,Mesothiliema,Mesotheleoma Mesosthelioma, Masesthilioma information:

 

 

 


free hit counter